| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | FANCJ uses its motor ATPase to destabilize protein-DNA complexes, unwind triplexes, and inhibit RAD51 strand exchange. | J Biol Chem | 2009 | 1.43 |
| 2 | BRCA-FA pathway as a target for anti-tumor drugs. | Anticancer Agents Med Chem | 2008 | 1.00 |
| 3 | Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning. | Proc Natl Acad Sci U S A | 2012 | 0.99 |
| 4 | Tetraplex binding molecules as anti-cancer agents. | Recent Pat Anticancer Drug Discov | 2006 | 0.82 |
| 5 | FAM190A rearrangements provide a multitude of individualized tumor signatures and neo-antigens in cancer. | Oncotarget | 2011 | 0.81 |